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NF-B is a key regulator of inflammation and 
innate immunity (Ghosh and Karin, 2002). 
It has long been considered the prototypical 
proinflammatory signaling pathway, as it is re-
sponsive to proinflammatory cytokines such as 
IL-1 and TNF, and is in charge of their synthesis 
(Ghosh and Karin, 2002). In addition, NF-B 
transcription factors activate expression of genes 
encoding cytokines, chemokines, adhesion mole-
cules, matrix metalloproteinases, cyclooxy-
genase 2, inducible nitric oxide synthase, and 
enzymes and molecules with microbicidal ac-
tivity (Li and Verma, 2002; Lawrence, 2009; 
Pasparakis, 2009). Through such genes, NF-B 
plays a key role in coordination of inflamma-
tion and immune responses. However, by con-
trolling cell proliferation and survival, NF-B 
also maintains tissue integrity and might play 
an antiinflammatory role (Karin and Lin, 2002; 
Pasparakis, 2009). NF-B protects cells from 
death by inducing expression of antiapoptotic 
proteins, including Bcl-xL, FLICE-like inhibi-
tory protein, and members of the inhibitor of 
apoptosis (IAP) family (Karin and Lin, 2002; 
Pasparakis, 2009).
NF-B activity is of particular importance 
for maintenance of epithelial barriers (Karin 
and Lin, 2002; Pasparakis, 2009), but it was also 
proposed that NF-B activation in epithelial 
cells can lead to production of inflammatory 
chemokines that recruit immune cells to the 
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Nuclear factor (NF)-B, activated by IB kinase (IKK), is a key regulator of inflammation, 
innate immunity, and tissue integrity. NF-B and one of its main activators and transcrip-
tional targets, tumor necrosis factor (TNF), are up-regulated in many inflammatory diseases 
that are accompanied by tissue destruction. The etiology of many inflammatory diseases is 
poorly understood, but often depends on genetic factors and environmental triggers that 
affect NF-B and related pathways. It is unknown, however, whether persistent NF-B 
activation is sufficient for driving symptomatic chronic inflammation and tissue damage. To 
address this question, we generated IKK(EE)IEC mice, which express a constitutively active 
form of IKK in intestinal epithelial cell (IECs). IKK(EE)IEC mice exhibit NF-B activation 
in IECs and express copious amounts of inflammatory chemokines, but only small amounts 
of TNF. Although IKK(EE)IEC mice exhibit inflammatory cell infiltration in the lamina 
propria (LP) of their small intestine, they do not manifest tissue damage. Yet, upon chal-
lenge with relatively mild immune and microbial stimuli, IKK(EE)IEC mice succumb to 
destructive acute inflammation accompanied by enterocyte apoptosis, intestinal barrier 
disruption, and bacterial translocation. Inflammation is driven by massive TNF production, 
which requires additional activation of p38 and extracellular-signal–regulated kinase 
mitogen-activated protein kinases (MAPKs).
© 2011 Guma et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months it 
is available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
T
h
e 
Jo
u
rn
al
 o
f 
E
xp
er
im
en
ta
l 
M
ed
ic
in
e
1890 NF-B sensitizes to MAPK-activating stimuli | Guma et al.
that persistent NF-B activation in epithelial cells is insuffi-
cient for driving symptomatic inflammation and tissue dam-
age, because synthesis of key inflammatory mediators, such as 
TNF, is subject to intricate transcriptional and posttranscrip-
tional controls.
RESULTS
IKK(EE)IEC mice exhibit persistent NF-B activation  
and target gene expression, but not tissue damage
To persistently activate NF-B in enterocytes, we generated 
transgenic (Tg) IKK(EE)IEC mice, which express a constitu-
tively active IKK variant, IKK(EE) (Delhase et al., 1999), 
from the villin control region (Madison et al., 2002). Hetero-
zygous IKK(EE)IEC mice were obtained at the expected 
Mendelian ratio and their general condition and survival did 
not differ from WT littermates. IKK(EE) was expressed 
throughout the intestine after a decreasing cephalocaudal gra-
dient that paralleled villin expression (Fig. 1 a). Enterocyte 
IB kinase activity was enhanced in IKK(EE)IEC mice 
(Fig. 1 b), resulting in nuclear translocation of p65 (RelA), RelB, 
and p50 (Fig. 1 c) and increased p65 DNA binding (Fig. 1 d).
To investigate NF-B–driven gene expression in IECs, 
we performed microarray analysis and confirmed representa-
tive results by quantitative (Q) real time (RT) PCR. Expres-
sion of 150 genes was increased >2.5-fold in IKK(EE)IEC 
enterocytes relative to WT counterparts (Fig. 1 e; Fig. S1 a; 
and Table S1). Many up-regulated genes are known NF-B 
targets, including Tnfaip3, Birc3, Nfkbia, Ccl20, Ccl2, Cxcl10, 
Icam1, Tnf, RelB, Csf1 and Bcl3. Chromatin immunoprecipi-
tation (ChIP) demonstrated RelA recruitment to the pro-
moters of several of these genes, including Tnf (Fig. 1 f). 
However, IKK(EE)IEC enterocytes exhibited a very large in-
crease in the secretion of several chemokines and cytokines, 
including CCL20, CCL2, and M-CSF, whose concentrations 
reached several nanograms/milliliter; however, the increase in 
TNF production was very modest and did not exceed 20– 
25 pg/ml (Fig. 1 g). This small increase in TNF protein secretion 
was in marked contrast to the 10–20-fold increase in its 
mRNA amounts (Fig. 1 e). In situ hybridization confirmed 
that TNF mRNA accumulated in IECs of IKK(EE)IEC mice 
(Fig. S1 b). Consistent with increased chemokine production, 
histological examination revealed marked infiltration with 
predominantly mononuclear leukocytes in the LP of the 
villus regions in jejunum and ileum of IKK(EE)IEC mice. 
This was paralleled by modest epithelial hyperplasia and crypt 
deepening without apparent loss of goblet cells or any epithe-
lial ulcerations (Fig. 1 h). Most IKK(EE)IEC mice displayed 
no morphological changes in the colon, although a small 
number of these mice had modest mucosal infiltration with 
mononuclear cells in the mid-to-distal colon without epithe-
lial ulceration. Submucosa and muscularis layers were not 
affected in the small intestine or colon of the Tg mice. Infiltration 
was apparent within 3 wk after birth, but did not progress over 
time. Even in mice older than 1 yr, small intestinal villi were 
intact without transmural infiltration or granulomas, and no 
spontaneous intestinal adenomas or carcinomas were detected. 
tissue, thereby initiating an inflammatory amplification cas-
cade (Barnes and Karin, 1997). Indeed, persistent activation of 
NF-B signaling pathways is often associated with chronic 
inflammatory diseases, such as rheumatoid arthritis (Handel 
et al., 1995; Tak et al., 2001), inflammatory bowel disease 
(Neurath et al., 1996; Kaser et al., 2010), psoriasis (Lizzul 
et al., 2005), and asthma (Edwards et al., 2009). NF-B activ-
ity and nuclear localization have been consistently detected in 
biopsies from such patients, and are accompanied by enhanced 
recruitment of inflammatory cells and production of pro-
inflammatory mediators such as IL-1, IL-6, and TNF (Barnes 
and Karin, 1997; Tak and Firestein, 2001; Pasparakis, 2009). 
Patients with elevated NF-B also suffer a worse outcome in 
septic shock/multiple organ failure (Böhrer et al., 1997; Arnalich 
et al., 2000; Liu and Malik, 2006). The etiology of these in-
flammatory diseases is unknown, but is likely to depend on a 
combination of genetic susceptibility and environmental trig-
gers, and single nucleotides polymorphisms in NF-B or 
related-pathways have been strongly implicated (Vereecke et al., 
2009; Zhang et al., 2011). It is unclear, however, whether the 
persistent activation of NF-B in epithelial cells is sufficient 
for driving chronic inflammation and tissue damage, given its 
aforementioned protective role.
NF-B is regulated by the activated by IB kinase (IKK) 
complex consisting of the IKK and IKK catalytic subunits 
and IKK/NEMO regulatory subunit (DiDonato et al., 1997; 
Ghosh and Karin, 2002; Rothwarf and Karin, 1999). To 
determine whether persistent epithelial cell activation of 
NF-B can drive chronic and destructive inflammation, we 
generated IKK(EE)IEC mice that selectively express consti-
tutively activated IKK (Delhase et al., 1999) in intestinal 
epithelial cells (IECs). It is well established that NF-B 
can stimulate transcription of genes encoding TNF and 
other proinflammatory cytokines and chemokines in IECs 
(Eckmann and Kagnoff, 2005). However, the absence of IKK 
or IKK/NEMO in IECs can result in tissue destruction caused 
by the extensive apoptosis, and this tissue damage can also re-
sult in increased inflammation (Chen et al., 2003; Egan et al., 
2004; Greten et al., 2004; Chae et al., 2006; Nenci et al., 2007; 
Spehlmann and Eckmann, 2009). Hence, in IECs, NF-B can 
have both pro- and antiinflammatory functions, making it 
difficult to predict which of these opposing functions would 
prevail in IKK(EE)IEC mice.
As expected, IKK(EE)IEC mice expressed copious 
amounts of inflammatory chemokines and cytokines, but 
unexpectedly produced only small amounts of TNF. The lamina 
propria (LP) of IKK(EE)IEC mice was infiltrated with immune 
cells, but this inflammation did not progress over time and 
the intestinal barrier remained intact. When challenged with 
pathogenic bacteria, LPS, or TCR agonists, IKK(EE)IEC 
mice succumbed to damaging acute inflammation accompa-
nied by IEC apoptosis and bacterial translocation, that was 
driven by massive TNF production, found to require addi-
tional activation of p38 and extracellular-signal–regulated 
kinase (ERK) mitogen-activated protein kinases (MAPK) on 
top of the already active NF-B. Our results strongly suggest 
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modestly increased relative to WT cells (Fig. S2 b). Yet, expres-
sion of several immunoregulatory molecules, including IL-10 
and PD-L1, which have been suggested to maintain mucosal 
tolerance (Denning et al., 2007), did not differ between WT 
and Tg mice (Fig. S2, b and c). We also detected a modest in-
crease in expression of other known regulators of inflamma-
tion, such as IL-12 or IL-23, in small intestinal extracts. This 
might be related to the increased number of F4/80+ LP cells 
in IKK(EE)IEC mice (Fig. S2 d). Small intestinal IELs and LP 
lymphocytes (LPLs) did not show increased cytokine (e.g., 
IFN-) staining (Fig. S2 e), or any major differences in their 
subpopulation distribution between WT and Tg mice (Table I), 
including Foxp3+ regulatory T cells, which have also been 
suggested to play a role in the maintenance of intestinal toler-
ance (Izcue et al., 2006). Immune responses to oral antigens 
and oral tolerance were also not altered in IKK(EE)IEC mice 
IKK(EE)IEC mice did not show any sign of diarrhea, and 
stool weight and water content did not differ between WT 
and Tg mice. There was no breakdown of the epithelial barrier 
as measured by fluorescein-dextran uptake (Fig. S1 c).
Immunofluorescence studies showed an influx of mainly 
F4/80+ and CD3+ cells into the small intestinal LP of 
IKK(EE)IEC mice (Fig. 2 a), paralleling increased ex-
pression of chemokines and cytokines important for macro-
phage and T cell recruitment and survival, such as CCL20, 
CCL2, CXL10, and M-CSF (Fig. 2 b and Fig. 1 e). Small in-
testinal intraepithelial lymphocytes (IELs) and CD3+ and 
F4/80+ cells in the LP were increased by 2- and 3.5-fold, 
respectively, in IKK(EE)IEC mice (Fig. 2 c). IKK(EE)IEC LP 
F4/80+ cells showed a mild increase in expression of several 
inflammatory cytokines (Fig. S2 a). TNF and IL-6 secretion 
elicited by stimulation with TLR ligands (CpG and LPS) was 
Figure 1. IKK(EE)IEC mice exhibit persistent NF-B activation, expression of NF-B target genes, but no tissue damage. (a) Lysates of WT 
and IKK(EE)IEC IECs were analyzed for villin and IKK expression by immunoblotting. Ln, lung; Sp, spleen; St, stomach; J, jejunum; I, ileum; C, colon.  
Representative of five experiments. (b) IKK activity was measured by immunocomplex kinase assay using GST-IB(1–79) as a substrate in lysates of WT  
and IKK(EE)IEC jejunal (J), ileal (I), and colonic (C) enterocytes. Representative of five experiments. (c) Presence of the indicated proteins in cytoplasmic 
and nuclear extracts of WT and IKK(EE)IEC enterocytes was examined by immunoblotting. Representative of five experiments. (d) Nuclear extracts of WT and 
IKK(EE)IEC enterocytes were analyzed for p65 DNA binding by ELISA. Results (absorbance/micrograms protein) are means ± SEM (n = 3). *, P < 0.05 versus 
WT. Data are representative of three independent experiments. (e) WT or IKK(EE)IEC enterocyte RNAs were analyzed in triplicates by Q-RT-PCR for expres-
sion of the indicated genes. mRNA amounts were normalized to Hprt mRNA. Results are means ± SEM (n = 4). *, P < 0.05 versus WT. Data are representa-
tive of four independent experiments. (f) ChIP was performed with a p65-specific antibody using fixed and sheared chromatin from WT and IKK(EE)IEC 
small bowel enterocytes. Promoter sequences were analyzed by Q-RT-PCR. Results are means ± SEM (n = 3). *, P < 0.05 versus WT. Data are representa-
tive of three independent experiments. (g) WT and IKK(EE)IEC enterocyte lysates (75 µg protein) were analyzed by ELISA for the indicated proteins. Results 
are means ± SEM (n = 3). *, P < 0.05 versus WT. Data are representative of four independent experiments. (h) Intestinal histology of WT and IKK(EE)IEC 
mice. Representative of 10 experiments.
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IECs (Fig. S3 a). Inflammatory cytokines, especially TNF, 
were substantially elevated in LPS-challenged IKK(EE)IEC 
mice (Fig. 3 c). Given the marked increase in TNF, we exam-
ined its role in the enhanced susceptibility of IKK(EE)IEC 
mice to LPS challenge. Although IKK(EE)IEC mice lacking 
TNF (IKK[EE]IEC x tnf/) or TNFR1 (IKK[EE]IEC x 
tnfrsf1/) exhibited similar histology and gene expression 
profiles to unchallenged IKK(EE)IEC mice, including im-
mune infiltration of the LP (Fig. 3 d and Fig. S3 b), they 
were fully protected from LPS-induced tissue damage (Fig. 3 e) 
and endotoxic shock (Fig. 3 f). Soluble TNFRII (Enbrel) 
was also protective (Fig. 3, e and f). IL-6 and IL-1 were 
also elevated in LPS-challenged IKK(EE)IEC mice, but 
neither IL-6 ablation (IKK[EE]IEC x il6/) nor treat-
ment with an IL-1 receptor antagonist (Anakinra) pro-
tected Tg mice from LPS-induced damage (Fig. S3, d and e). 
Mice were also treated with a cocktail of antibiotics to de-
termine the role of the intestinal microbiota in the exacer-
bated mucosal responses of IKK(EE)IEC mice, but the 
antibiotics treatment did not protect Tg mice from LPS-
induced apoptosis.
(Fig. S2, f and g). In summary, persistent NF-B activation in 
IECs results in enhanced localized macrophage and T cell 
infiltration, but does not cause destructive symptomatic in-
testinal inflammation, massive TNF production, or altered 
lymphocyte homeostasis or responsiveness.
Small intestinal apoptosis and enhanced mortality  
is associated with elevated TNF production in challenged 
IKK(EE)IEC mice
We next examined whether constitutive NF-B activation 
protects the epithelium from inflammatory challenge. Un-
expectedly, IKK(EE)IEC mice were extremely sensitive and 
exhibited considerable mucosal damage upon challenge with 
all tested stimuli. Administration of a dose of LPS that did not 
cause mortality in WT mice led to endotoxic shock, with a 
large and rapid drop in body temperature, and high mortality in 
IKK(EE)IEC mice (Fig. 3 a). Even a low LPS dose (0.1 mg/kg) 
induced severe small intestinal injury characterized by fluid-filled 
dilations (Fig. 3 b), apoptosis, which was most severe in crypts, 
and shortening of villi (Fig. 3 b). This occurred despite the 
enhanced expression of antiapoptotic genes in IKK(EE)IEC 
Figure 2. The IKK(EE)IEC small intestinal LP is infiltrated with F4/80 and CD3+ cells. (a) Frozen sections of WT or IKK(EE)IEC jejunum and colon 
were stained for the indicated markers and visualized by immunofluorescence. Representative of five experiments. (b) RNAs from WT or IKK(EE)IEC  
enterocytes were subjected to gene expression profiling using whole-genome oligonucleotide arrays (Agilent). Shown are the expression levels of chemokine 
genes. Positive or negative values represent fold changes between IKK(EE)IEC mice and littermate controls (n = 2). (c) Small intestinal IELs and LPLs were 
isolated from WT or IKK(EE)IEC mice and counted. Percentages of F4/80 and CD3+ cells were determined by flow cytometry in cells gated for CD45.  
Results are means ± SEM (n = 6). *, P < 0.05 versus WT. Data are representative of three independent experiments.
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These results suggested that although NF-B is activated 
in Tg enterocytes and is sufficient for increasing basal TNF 
gene transcription, accumulation of TNF mRNA and espe-
cially protein may depend on posttranscriptional events. 
MAPK signaling pathways, both p38 MAPK and ERK, 
play important roles in posttranscriptional regulation of 
TNF production (Kotlyarov et al., 1999; Dumitru et al., 2000; 
Rousseau et al., 2008; Xu and Derynck, 2010; Gais et al., 
2010). LPS administration enhanced p38, MK2, and ERK 
phosphorylation in IECs of both WT and Tg mice (Fig. 5 a). 
TNF-–converting enzyme (TACE) activity was also en-
hanced after LPS administration, but the extent of elevation 
was similar in both groups of mice (Fig. S5 a). Oral adminis-
tration of RWJ 67657, a p38 MAPK inhibitor (Wadsworth 
et al., 1999), and PD184352, a specific MEK-1/2 inhibitor, 
decreased phosphorylation of the corresponding MAPKs and 
their targets (Fig. S5 b), serum TNF (Fig. 5 b), and its release 
from enterocytes (Fig. 5 c), and protected IKK(EE)IEC mice 
from endotoxic shock (Fig. 5 d). These results suggest that ad-
ditional activation of both MAPK pathways on top of the 
already active NF-B is necessary to induce TNF produc-
tion and epithelial damage in IKK(EE)IEC mice. We also 
examined whether IKK(EE)IEC IECs were more sensitive to 
TNF-induced killing than WT IECs. Exogenous administra-
tion of TNF induced IEC apoptosis in IKK(EE)IEC x tnf/ 
mice, although to a lesser extent than in IKK(EE)IEC mice 
(Fig. 5 e; 3.6 ± 0.8 vs. 8.7 ± 1.2 apoptotic cells per crypt; 
P < 0.001), but did not induce apoptosis in tnf/ and WT mice.
Citrobacter rodentium infection and CD3 activation cause 
loss of barrier function in IKK(EE)IEC mice
To further investigate the effect of chronic NF-B activation 
on maintenance of intestinal barrier function and innate im-
munity, we challenged IKK(EE)IEC mice with the Gram-
negative bacterium C. rodentium, an attaching and effacing 
(A/E) pathogen that colonizes the mouse colon, activates 
MAPK signaling in colonic IECs (Fig. 6 a), and typically leads 
to crypt hyperplasia and mucosal inflammation before its 
clearance from immunocompetent mice (Borenshtein et al., 
2008). Tg and WT mice had similar fecal bacterial counts 
after C. rodentium infection (Fig. 6 b), indicating similar bacte-
rial burden, immune response, and bacterial clearance. How-
ever, Tg mice had greater colonic mucosal ulceration and 
crypt apoptosis (Fig. 6 c) and higher liver bacterial counts 
than their WT counterparts (Fig. 6 b), suggesting that epithe-
lial barrier disruption enhanced systemic bacterial spread. 
IKK(EE)IEC x Tnf/ mice were protected from the increase 
in C. rodentium–induced colon damage (Fig. 6 d) and subse-
quent bacterial translocation, as the log10CFU/gram liver for 
WT, IKK(EE)IEC, and IKK(EE)IEC x Tnf/ mice at 14 d 
after infection were 0, 3.2 ± 0.5, and 0.8 ± 0.35, respectively. 
IKK(EE)IEC mice were also extremely sensitive to oral ad-
ministration of the irritant dextran sulfate salt (DSS), which 
causes acute intestinal inflammation, as they developed much 
more severe colonic ulceration and displayed increased mor-
tality compared with WT mice (Fig. S6, a and b). This effect 
Elevated TNF production and mortality in challenged 
IKK(EE)IEC mice depend on MAPK activation
To identify sources of TNF in LPS-challenged IKK(EE)IEC 
mice, we isolated LP F4/80+ cells before and after LPS 
challenge, and found that their TNF mRNA expression did 
not differ between Tg and WT mice, although IL-6 and 
IL-12 mRNAs were higher in Tg cells (Fig. S4). Yet, the 
number of F4/80+ LP cells was increased in IKK(EE)IEC 
mice, suggesting that they may contribute to total circulat-
ing TNF. In contrast, membrane-associated and especially 
soluble TNF were dramatically increased in IECs of LPS-
challenged IKK(EE)IEC mice (Fig. 4, a–c). Despite the 
threefold increase in TNF mRNA (Fig. 4 d), LPS adminis-
tration led to only a small further increase of p65 nuclear 
translocation and DNA binding above the basal level of 
nonstimulated IKK(EE)IEC enterocytes (Fig. 4, e and f ). 
A lower LPS dose increased TNF protein production by Tg 
enterocytes without causing any further increase in its 
mRNA amounts, but did not elicit TNF production by 
WT IECs (Fig. 4, g and h).
Table I. Sizes of Peyer’s patch, MLN, IEL, and LPL 
subpopulations
WT EE
PP
  CD4+ 11.25 ± 1.3 12 ± 1.4
  CD8+ 3.75 ± 0.5 3.4 ± 0.3
  B220+ 86 ± 5.1 87 ± 7.2
  CD11c+ 0.5 ± 0.1 0.3 ± 0.2
MLN  
  CD4+ 31 ± 2.5 30 ± 1.7
  CD8+ 21 ± 1.8 20 ± 1.2
  B220+ 26 ± 3.5 28 ± 2.1
  CD11c+ 4 ± 0.5 3 ± 0.7
IELs  
Percentage within CD3+ cells: 
  TCR+ 45.2 ± 3.4 45.1 ± 2.3
  TCR+ 54.8 ± 4.5 54.9 ± 4.3
Percentage within TCR+ cells: 
  CD8+ CD8- 41.2 ± 2.3 37 ± 3.4
  CD8+ 30.1 ± 1.5 30.2 ± 2.5
  CD4+ 24 ± 1.3 22 ± 1.5
Percentage within TCR+ cells: 
  CD8+ CD8- 83 ± 3.2 82 ± 2.4
  CD8+ 4.1 ± 1.1 4.2 ± 0.9
LPLs  
Percentage within TCR+ cells: 
  CD8+ 15.3 ± 1.4 12.7 ± 2.8
  CD4+ 78.2 ± 3.4 78.4 ± 2.9
  CD4+Foxp3+ 17.2 ± 2.3 18.1 ± 3.2
Peyer’s patches (PP), MLN, IEL, and LPL subpopulations. Isolated cells from MLN, 
small intestinal PP, LPLs and IELs of WT or IKK(EE)IEC (n = 4) were stained with 
labeled antibodies and analyzed by FACS.
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apoptosis and small intestinal damage in normal mice (Miura 
et al., 2005). In IKK(EE)IEC mice, however, this treatment 
caused massive enterocyte apoptosis, followed by villous 
shortening (Fig. 7 a) and a rapid drop in body temperature 
(Fig. 7 b), as well as increased TNF protein amounts in serum 
(Fig. S7 a) and release by IECs without a further increase in 
TNF mRNA (Fig. 7, c and d). As seen with LPS, anti-CD3 
administration caused MAPK activation in enterocytes from 
was again dependent on TNF, as IKK(EE)IEC x Tnf/ mice 
were partially protected against acute DSS-induced colitis, as 
shown in Fig. S6 c.
Intestinal inflammation is associated in some diseases with 
exaggerated and poorly controlled T cell–mediated immune 
responses (Kaser et al., 2010). To mimic antigen stimulation of 
small intestinal T cells, we injected mice with a low dose of a 
CD3-activating antibody that triggers only minimal enterocyte 
Figure 3. Small intestinal apoptosis and increased endotoxin-induced mortality associated with elevated TNF production in IKK(EE)IEC 
mice. (a) Rectal temperature and survival of WT (gray diamonds) and IKK(EE)IEC (black squares) mice after LPS (5 mg/kg E. coli O111:B4) injection. Results 
are means ± SEM (n = 8). *, P < 0.05 versus WT. Data are pooled from three independent experiments. (b) Abdomens of WT and IKK(EE)IEC mice 4 h after 
LPS (1 mg/kg) injection. Arrow points at fluid-filled dilated small bowel in Tg mice. Jejunal sections were stained with either H&E (top) or by an in situ 
TUNEL assay (bottom). Representative of 10 experiments. (c) Circulating TNF and IL-1 after LPS administration. Results are means ± SEM (n = 4).  
*, P < 0.05 versus WT. Data are representative of three independent experiments. (d) Intestinal histology of IKK(EE)IEC x tnfa/ and IKK(EE)IEC x tnfrsf1a/ 
mice. Jejunal sections were H&E stained. Representative of five experiments. (e) The indicated mouse strains were analyzed 4 h after LPS injection with or 
without an accompanying dose of Enbrel (sTNFRII) as indicated. Small intestinal sections were stained with H&E. Representative of three experiments.  
(f) Rectal temperature and survival of WT (gray diamond), IKK(EE)IEC (black square), IKK(EE)IEC x tnfsrf1/ (black circle), IKK(EE)IEC x tnf/ (gray  
triangle), IKK(EE)IEC + sTNFRII (black triangle) mice after LPS injection. Results are means ± SEM (n = 3). Survival of WT, IKK(EE)IEC x tnfsrf1/ (black 
circle), IKK(EE)IEC x tnf/ (gray triangle), and IKK(EE)IEC + sTNFRII (black triangle) is 100%. *, P < 0.05 versus IKK(EE)IEC. Data are representative of three 
independent experiments.
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DISCUSSION
NF-B has been implicated in the pathogenesis of many 
inflammation-related diseases (Tak and Firestein, 2001; Pasparakis, 
2009), and genetic manipulations that lead to increased 
NF-B activity often trigger inflammation-related pathol-
ogies (Beg et al., 1995; Klement et al., 1996). Other studies 
confirmed that NF-B inhibition has antiinflammatory effects 
in vivo (Greten et al., 2004; Broide et al., 2005). However, several 
recent studies have surprisingly shown that NF-B inhibition 
both WT and Tg mice (Fig. 7 e). No significant differences in 
intracellular cytokines were found between Tg and WT lym-
phocytes after anti-CD3 injection (Fig. S7, b and c). Yet, other 
immune cells that are indirectly activated may also contribute to 
TNF secretion or IEC apoptosis. Ablation of TNF or TNFR1 
or Enbrel administration protected IKK(EE)IEC mice from 
anti-CD3–induced tissue damage and pharmacological inhi-
bition of p38 partially decreased enterocyte TNF production 
(Fig. 7 f and Fig. S7 d).
Figure 4. Membrane-associated and especially soluble TNF are dramatically increased in IECs of LPS-challenged IKK(EE)IEC mice.  
(a) Lysates of small intestinal enterocytes were prepared when indicated after LPS injection and analyzed for TNF expression by immunoblotting (trans-
membrane, 26 kD; soluble, 17 kD). Representative of three experiments. (b) Frozen sections of WT or IKK(EE)IEC jejuna prepared 2 h after LPS injection 
were stained with anti-TNF antibody and visualized by immunofluorescence. Representative of three experiments. (c) Lysates of small intestinal  
enterocytes (75 µg protein) of indicated genotypes were prepared when indicated after LPS injection and analyzed for TNF content by ELISA. Results  
are means ± SEM (n = 4). *, P < 0.05 versus WT. Data are representative of four independent experiments. (d) RNAs from small intestinal enterocytes 
of indicated genotypes were prepared when indicated after LPS injection and analyzed in triplicates by Q-RT-PCR for TNF mRNA and normalized to  
Hprt mRNA. *, P < 0.05 versus WT; #, P < 0.05 versus other time points in IKK(EE)IEC mice. Results are means ± SEM (n = 4). Data are representative 
of four independent experiments. (e and f) LPS administration results in only a mild increase of p65 nuclear translocation and DNA binding in 
IKK(EE)IEC enterocytes. (e) WT and IKK(EE)IEC enterocytes were isolated 30 min after LPS injection and separated into cytosolic (C) and nuclear (N) 
fractions that were analyzed for their content of the indicated proteins by immunoblotting. Representative of two experiments. (f) Nuclear extracts of 
WT and IKK(EE)IEC enterocytes isolated 30 min after LPS injection were analyzed for p65 DNA binding by ELISA. Results are means ± SEM (n = 3).  
*, P < 0.05 versus control. Data are representative of two independent experiments. (g and h) Low LPS dose administration induces TNF protein produc-
tion by Tg enterocytes without a further increase in its mRNA amounts. (g) Lysates of small intestinal enterocytes (75 µg protein) of indicated geno-
types prepared when indicated after low LPS dose (0.2 mg/kg) injection were analyzed for TNF content by ELISA. *, P < 0.05 versus WT. Results are 
means ± SEM (n = 3). Data are representative of three independent experiments. (h) RNAs from small intestinal IECs prepared when indicated after 
low LPS dose (0.2 mg/kg) injection were analyzed in triplicates by Q-RT-PCR for TNF mRNA amounts and normalized to Hprt mRNA. Results are  
means ± SEM (n = 3). *, P < 0.05 versus WT. Data are representative of three independent experiments.
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in nonimmune, epithelial, or parenchymal cells triggers the 
spontaneous development of severe inflammatory condi-
tions (Pasparakis, 2009). In IECs, for instance, NF-B 
mainly plays a protective and antiinflammatory role. IEC-
specific ablation of the NEMO/IKK regulatory subunit, 
or of IKK, resulted in complete or partial loss of barrier 
function, bacterial translocation, and severe inflammation 
(Chen et al., 2003; Egan et al., 2004; Greten et al., 2004; 
Chae et al., 2006; Nenci et al., 2007). The ability of NF-B 
to maintain barrier function and immune homeostasis may 
depend on suppression of enterocyte death and expression 
of barrier function genes and defensins. This function may 
be essential, as the intestinal epithelium has an important 
function in the maintenance of intestinal immune homeo-
stasis. By forming a mechanical barrier and producing anti-
microbial peptides, IECs prevent bacteria from invading 
the mucosa, where they could encounter immune cells and 
induce inflammation.
Our results suggest that persistent NF-B activation in 
IECs is sufficient for expression of large amounts of inflam-
matory chemokines, dramatic mononuclear cell infiltration 
into the small intestinal LP, and Tnf gene transcription, but is 
insufficient for substantial production of TNF protein and 
therefore cannot drive symptomatic intestinal inflammation 
by itself. Consequently, IKK(EE)IEC mice did not show any 
sign of diarrhea or intestinal bleeding, and their survival did 
not differ from WT littermates. The noteworthy absence of 
epithelial barrier breakdown despite the overall elevated 
mucosal cytokine levels could support the concept of a pro-
tective role of intestinal epithelial NF-B. Increased expres-
sion of antiapoptotic genes together with the low production 
of TNF protein by the unchallenged IKK(EE)IEC IECs could 
shift the balance toward maintenance of the barrier and intes-
tinal homeostasis.
However, IKK(EE)IEC mice exposed to relatively mild 
inflammatory and immune stimuli, at doses that trigger only 
modest responses in WT mice, showed epithelial apoptosis, 
intestinal barrier disruption, and subsequent bacterial trans-
location. These unexpected results are counterintuitive, given 
the role of NF-B in maintenance of barrier function and 
control of bacterial translocation. These stimuli, which 
activate additional signaling pathways, especially MAPK, 
greatly enhanced TNF production in IKK(EE)IEC mice and 
led to a widespread epithelial apoptosis and disruption of in-
testinal integrity. However, neither LPS, which signals via 
TLR4, which is expressed mainly on macrophages and den-
dritic cells, nor anti-CD3, which activates TCR, can directly 
activate MAPKs in IECs. Most likely, they induce production 
of a cytokine, possibly TNF itself, which acts on IECs to 
activate MAPKs. Curiously, none of the cytokines produced 
by IKK(EE)IEC enterocytes are sufficient for autocrine or 
paracrine activation of MAPKs in these cells. IKK(EE)IEC 
enterocytes were also sensitive to circulating TNF, suggesting 
that persistent NF-B activation up-regulates other proapop-
totic pathways that, together with the increase in TNF produc-
tion, shift the balance toward apoptosis.
Figure 5. Elevated TNF production in LPS-challenged  
IKK(EE)IEC mice and mortality depend on MAPK activation.  
(a) Lysates from small intestinal enterocytes prepared 30 min after LPS chal-
lenge were analyzed for expression and phosphorylation of the indicated 
proteins by immunoblotting. Representative of three experiments. (b) Circu-
lating TNF after LPS injection (0.2 mg/kg) with or without RWJ67657 (RWJ)  
or PD184352 (PD). Results are means ± SEM (n = 3). *, P < 0.05 versus 
IKK(EE)IEC; #, P < 0.05 versus IKK(EE)IEC with RWJ or PD. Data are represen-
tative of three independent experiments. (c) Small intestinal enterocyte lysates 
(75 µg protein) of indicated genotypes were prepared 90 min after LPS injec-
tion (0.2 mg/kg) with or without RWJ67657 (RWJ) or PD184352 (PD) and 
analyzed for TNF content by ELISA. Results are means ± SEM (n = 3).  
*, P < 0.05 versus IKK(EE)IEC; #, P < 0.05 versus IKK(EE)IEC with RWJ or PD. 
Data are representative of three independent experiments. (d) Rectal tempera-
ture and survival after LPS injection (0.2 mg/kg) with or without RWJ67657 
(RWJ) or PD184352 (PD). Results are means ± SEM (n = 6). WT (gray diamond), 
IKK(EE)IEC (black square), IKK(EE)IEC + RWJ (black circle), IKK(EE)IEC + PD 
(gray triangle), and IKK(EE)IEC + RWJ + PD (black triangle). Survival of WT 
(gray diamond) and IKK(EE)IEC + RWJ + PD (black triangle) is 100%, and 
survival of IKK(EE)IEC + RWJ (black circle) and IKK(EE)IEC + PD (gray triangle) 
is 100% up to 6 h. *, P < 0.05 for WT and IKK(EE)IEC + RWJ + PD versus 
IKK(EE)IEC; #, P < 0.05 for IKK(EE)IEC versus IKK(EE)IEC + RWJ or PD, and  
WT and IKK(EE)IEC + RWJ + PD versus IKK(EE)IEC + RWJ or PD. Data are 
pooled from two independent experiments. (e) The indicated mouse strains 
were analyzed 4 h after TNF administration (mice were injected i.v. with 2 µg 
of recombinant murine TNF). Small intestinal sections were stained with H&E. 
Arrows point at apoptotic cells. Representative of three experiments.
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maintained under standard conditions at a University of California at 
San Diego animal facility accredited by the American Association for 
Accreditation of Laboratory Animal Care. All animal protocols were 
approved by the institutional review board, following National Institutes 
of Health guidelines.
Reagents. LPS (Escherichia coli O111:B4; Sigma-Aldrich) was injected i.p. at 
a dose of 5 mg/kg unless otherwise indicated. Recombinant mouse TNF 
from R&D Systems was injected i.v. at dose of 2 µg/mouse. Antibody against 
CD3 (clone 145-2C11; BD) was injected i.p. at a dose of 12.5 µg/mouse, 
unless otherwise indicated. RWJ 67657 (Wadsworth et al., 1999; p38 MAPK 
inhibitor) and PD184352 (MEK-1/2 inhibitor) were purchased from Tocris 
Bioscience and Selleck Chemicals LLC, respectively, diluted in 0.1 N HCl, 
and administrated by oral gavage (50 mg/kg). Enbrel (sTNFRII; Amgen) was 
administrated i.v. at 5 mg/kg. IL-1 receptor antagonist (IL-1Ra or Anakinra; 
Amgen) was administered i.v. at 300 mg/kg. Drugs were administrated 
30 min before challenge.
Flow cytometry, intracellular cytokine staining, and cell sorting. For 
intracellular cytokine staining, surface staining was performed for 25 min 
with the corresponding cocktail of fluorescently labeled antibodies. After 
surface staining, cells were resuspended in Fixation/Permeabilization solution 
(Cytofix/Cytoperm kit; BD), and intracellular cytokine and FoxP3 staining 
was performed according to the manufacturer’s protocol. For cell sorting, 
a FACS Diva cell sorter (BD) was used. Data were analyzed using FlowJo 
software (Tree Star).
Histological analysis and TUNEL assay. Intestines were removed, opened 
longitudinally, cleaned, processed as “Swiss rolls,” and fixed in 10% phos-
phate-buffered formalin for 24 h. Fixed tissues were embedded in paraffin, 
and 5-µm sections were prepared and stained with hematoxylin and eosin 
(H&E). For immunofluorescence studies, tissues were frozen in OCT com-
pound, cut on a cryomicrotome, air-dried, and fixed in acetone. The sections 
were incubated overnight at 4°C with antibodies against F4/80 (AbD 
Serotec), CD11c, B220 (BD), CD3, and TNF (Abcam). In situ TUNEL assay 
was performed using ApoAlert DNA fragmentation assay kit (Takara Bio 
Inc.). Samples were examined under a microscope (Axioplan 2; Carl 
Zeiss, Inc.).
We speculate that a similar mechanism may underlie the 
pathogenesis of chronic inflammatory disorders with relaps-
ing acute flare-ups, such as inflammatory bowel diseases, pso-
riasis, or rheumatoid arthritis, in which relatively quiescent 
periods without overt symptomatic inflammation erupt into 
acute inflammatory flare-ups upon encounter of poorly 
defined environmental challenges. In these disorders, either 
direct or indirect chronic NF-B activation was observed in 
nonimmune cells such as IECs, keratinocytes, and synovio-
cytes (Li and Verma, 2002), single nucleotide polymorphisms 
in NF-B pathway components were found (Vereecke et al., 
2009). In addition, these disorders respond to anti-TNF ther-
apy (Sfikakis, 2010). The new findings may also explain 
microbial translocation in patients and animals experiencing 
gut insults that increase NF-B and cause massive TNF 
production, such as intestinal ischemia, necrotizing entero-
colitis and obstruction (Chen et al., 2003). Our results may also 
be relevant to the increased translocation of enteric bacteria 
seen in AIDS patients, who are known to have elevated 
TNF (Stockmann et al., 2000). Given the increase in IL-1–
driven inflammation caused by IKK inhibition (Greten 
et al., 2007; Hsu et al., 2011), inhibition of MAPKs (ERK and 
p38) or anti-TNF therapy may be the preferred treatments 
for such disorders.
MATERIALS AND METHODS
Mice. IKKEE cDNA (Delhase et al., 1999) was PCR-amplified and 
inserted into a plasmid containing the 12.4-kb Villin promoter (D. Gumucio, 
University of Michigan, Ann Arbor, MI; Madison et al., 2002). The 15.7-kb 
expression cassette was excised by a PmeI digest, purified, and injected into 
fertilized C57BL/6 oocytes to derive founder mice, one of which transmitted 
the IkkEE transgene. Tg mice were crossed to tnf/, tnfrsf1/, and il6/ 
mutants, also in the C57BL/6 background, purchased from The Jackson 
Laboratory. Mice used in the experiments were 8–12 wk old and were 
Figure 6. C. rodentium infection causes 
loss of barrier function and enterocyte 
apoptosis in IKK(EE)IEC mice. (a) Lysates 
of small intestinal WT and IKK(EE)IEC  
enterocytes prepared 6 d after C. rodentium 
challenge were analyzed for expression and 
phosphorylation of the indicated proteins by 
immunoblotting. Representative of four  
experiments. (b) C. rodentium counts in stool 
and liver were determined by CFU assay. 
Results are means ± SEM (n = 8). *, P < 0.05 
versus WT. Data are representative of three 
independent experiments. (c) WT and 
IKK(EE)IEC mice were analyzed 14 d after  
C. rodentium infection. Colon sections were 
stained with either H&E (top) or by an in situ 
TUNEL assay (bottom). Representative of 
three experiments. (d) Indicated mouse 
strains were analyzed 14 d after C. roden-
tium infection. Colon sections were H&E 
stained. Arrows point at apoptotic cells.  
Representative of two experiments.
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CA, sc-372) as described (Lee et al., 2006). Precipitated material was ana-
lyzed by Q-RT-PCR. Primer sequences are available upon request. Al-
though not shown, we have confirmed the results of the anti-p65 ChIP 
with an anti-PolII antibody (Santa Cruz Biotechnology Inc., San Jose, 
CA, sc-899).
In situ hybridization. Intestinal paraffin sections were hybridized to 
anti-TNF probe (IMAGE clone #8860739) at 65°C for 72 h as described 
(Gregorieff et al., 2005).
C. rodentium infection. Mice were infected (5 × 108 bacteria) by oral 
gavage. Bacterial counts were determined as previously described (Spehlmann 
et al., 2009).
Intestinal permeability in vivo. In vivo permeability assay to assess barrier 
function was performed using a FITC-labeled dextran method. Food and 
water were withdrawn for 4 h, and mice were gavaged with permeability 
tracer (60 mg/100 g body weight of FITC-labeled dextran; FD-4; Sigma- 
Aldrich). Serum was collected retroorbitally 4 h after FD-4 gavage, and fluo-
rescence intensity of each sample was measured (excitation, 492 nm; emission, 
525 nm).
Kinase assays. Enterocytes were lysed and immunoprecipitated with an 
anti-IKK antibody (BD). The immune complexes were incubated with 
GST-IB(1–79) in the presence of [32P]ATP. Proteins were resolved by 
SDS-PAGE and transferred to a nitrocellulose membrane that was exposed 
to x-ray film and hybridized with antibodies against IKK (Millipore) and 
IKK (Santa Cruz Biotechnology, Inc.).
Expression array profiling. Total RNA (isolated by RNeasy kit; 
QIAGEN) was prepared from enterocytes obtained from small intestines of 
IKK(EE)IEC and WT littermates. Purified RNA, 0.5 µg per sample, was 
labeled using the LRILAK PLUS two-color low RNA input Linear Ampli-
fication kit, and then hybridized to a mouse whole-genome microarray 4 × 
44K 60 mer slide according to the manufacturer’s instructions (Agilent). Two 
biological replicates were performed for each experimental condition. GEO 
submission number is GSE29701.
Isolation of IELs and LPLs. IELs and LPLs were isolated as previously 
described (Mucida et al., 2007).
Immunoblotting. Whole enterocyte extracts were obtained by lysing cells 
in 1% SDS and 10 mM Tris-HCl (pH 7.4). Cytoplasmic and nuclear extracts 
were obtained as previously described (Rius et al., 2008). Proteins were sepa-
rated by SDS-PAGE and transferred to nitrocellulose membranes that were 
incubated with antibodies against IKK (Millipore); IB, IB, IB, p65, 
RelB, p50, HDAC1, p38, villin (Santa Cruz Biotechnology, Inc.); TNF (R&D 
Systems); phospho-MK2, MK2, phospho-p38, phospho-ERK, and ERK1/2 
(Cell Signaling Technology); and actin and tubulin (Sigma-Aldrich).
p65 DNA binding. Nuclear extracts were obtained as previously described 
(Rius et al., 2008) and analyzed for p65 DNA binding by ELISA (Cayman 
Chemical) according to the manufacturer’s instructions.
ChIP. Epithelium from small intestine was scraped into 1% formaldehyde 
solution and fixed for 10 min at room temperature. Chromatin was pre-
cipitated with a p65 antibody (Santa Cruz Biotechnology Inc., San Jose, 
Figure 7. CD3 activation causes loss of 
barrier function and enterocyte apoptosis in 
IKK(EE)IEC mice. (a) Indicated mouse strains 
were analyzed 4 and 16 h after anti-CD3  
(12.5 µg/mouse) administration. Jejunal sections 
analyzed at 4 h were stained with either H&E 
(top) or by in situ TUNEL assay (bottom). Jejunal 
sections analyzed at 16 h were H&E stained. 
Representative of four experiments. (b) Rectal 
temperature of WT (gray diamonds) and 
IKK(EE)IEC (black squares) mice after anti-CD3 
injection. Results are means ± SEM (n = 4).  
*, P < 0.05 versus WT. Data are representative of 
three independent experiments. (c) Lysates of 
small intestinal IECs were prepared 2.5 h after 
CD3 injection and analyzed (75 µg protein) for 
TNF content by ELISA. Results are means ± SEM 
(n = 4). *, P < 0.05 versus WT; # P < 0.05 versus 
time 0. Data are representative of three inde-
pendent experiments. (d) RNAs from small intes-
tinal WT or IKK(EE)IEC IECs were prepared 1.5 h 
after CD3 injection and analyzed in triplicates by 
Q-RT-PCR for TNF mRNA amounts that were 
normalized to Hprt mRNA. Results are means ± 
SEM (n = 3). *, P < 0.05 versus WT; #, P < 0.05 
versus time 0. Data are representative of three 
independent experiments. (e) WT and IKK(EE)IEC 
enterocytes lysates prepared 40 and 60 min 
after anti-CD3 injection were analyzed for ex-
pression and phosphorylation of the indicated 
proteins by immunoblotting. Representative of 
three experiments. (f) Small intestinal enterocyte 
lysates (75 µg protein) were prepared 90 min 
after anti-CD3 injection (6.25 µg/mouse) in the absence or presence of RWJ 67657 and analyzed for TNF content by ELISA. Results are means ± SEM (n = 3).  
*, P < 0.05 versus IKK(EE)IEC. Data are representative of three independent experiments.
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Intestinal antigen uptake and processing. Naive CD4+ T cells were iso-
lated from spleens and mesenteric LNs (MLNs) of OT-2/CD90.1+ mice via 
negative selection (MACS; Miltenyi Biotec). The purity of CD4+ cells ex-
ceeded 80%. Cells were labeled with 5 µM CFSE for 5 min at room tempera-
ture, washed twice with PBS, and i.v. injected into either IKK(EE)IEC or 
WT recipient mice. Mice were fed with oral OVA: high dose (20% OVA diet; 
Research Diets Inc.) or low dose (0.1% grade II OVA; Sigma-Aldrich) in 
nonacidified drinking water. On day 5, MLNs were analyzed for the presence 
of proliferating CD90.1/CD4+ T cells.
OVA oral tolerance. Both WT and IKK(EE)IEC mice were fed with 20% 
OVA diet (Research Diets Inc.) for 2 d. On day 7, mice were immunized by 
a s.c. tail-base injection of 50 µg of grade V OVA in 100 µl of complete 
Freud’s adjuvant (Sigma-Aldrich). On day 22, anti-OVA antibody concentra-
tions in serum were determined by ELISA.
TACE activity. Enterocytes were lysed and analyzed for TACE activity by 
SensoLyte 520 TACE (-Secretase) Activity Assay kit Fluorometric (Anaspec) 
according to the manufacturer’s instructions.
Statistical analysis. Data are expressed as mean ± SEM. The analysis used 
unpaired Student’s t test for comparing two groups and ANOVA for multiple 
group comparisons. Bonferroni post-hoc tests were used for multiple pair-
wise comparisons. All statistical analyses were performed using the SPSS 15.0 
(SPSS) statistical package. Results were considered significant at P < 0.05.
Online supplemental material. Fig. S1 shows that IKK(EE)IEC mice ex-
hibit persistent NF-B target gene expression, but no tissue damage. Fig. S2 
shows that persistent NF-B activation in IECs does not cause altered lym-
phocyte homeostasis and responsiveness. Fig. S3 shows that TNF or TNFR1 
deficiencies in IKK(EE)IEC mice do not alter intestinal histology or gene ex-
pression, and IL6 ablation and IL-1 receptor antagonist (Anakinra) treatment 
does not protect IKK(EE)IEC mice from intestinal apoptosis after LPS injec-
tion. Fig. S4 shows that TNF expression in small intestinal F4/80+ LP cells 
after LPS injection does not differ between WT and IKK(EE)IEC. Fig. S5 
shows that TACE activity does not differ between WT and IKK(EE)IEC. Fig. S6 
shows that DSS exposure cause an increase of colonic damage and high mor-
tality in IKK(EE)IEC mice. Fig. S7 shows that WT or IKK(EE)IEC small 
intestinal T cells do not exhibit significant differences in cytokine production 
after anti-CD3 injection, and anti-TNF therapy protects IKK(EE)IEC mice 
from anti-CD3–induced tissue damage. Table S1 shows the expression pro-
files of WT and IKK(EE)IEC IECs. Online supplemental material is available 
at http://www.jem.org/cgi/content/full/jem.20110242/DC1.
We are grateful to Dr. D. Gumucio from the University of Michigan for the plasmid 
containing the 12.4 kb Villin promoter.
M. Guma was supported by the Arthritis Foundation. M.E. Spehlmann was 
supported by postdoctoral fellowships from the German Research Foundation and 
Mucosaimmunologie gemeinnützige Forschungsgesellschaft Educative Science.  
Work in M. Karin, M.F. Kagnoff, H. Cheroutre, and L. Eckmann’s laboratories was 
supported by grants from the National Institutes of Health and Wm. K. Warren 
Foundation. M. Karin is an American Cancer Society Research Professor.
The authors have no conflicting financial interests.
Submitted: 2 January 2011
Accepted: 1 July 2011
REFERENCES
Arnalich, F., E. Garcia-Palomero, J. López, M. Jiménez, R. Madero, J. Renart, 
J.J. Vázquez, and C. Montiel. 2000. Predictive value of nuclear factor 
kappaB activity and plasma cytokine levels in patients with sepsis. Infect. 
Immun. 68:1942–1945. doi:10.1128/IAI.68.4.1942-1945.2000
Barnes, P.J., and M. Karin. 1997. Nuclear factor-kappaB: a pivotal transcription 
factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066–1071.
Beg, A.A., W.C. Sha, R.T. Bronson, and D. Baltimore. 1995. Constitutive 
NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in 
1900 NF-B sensitizes to MAPK-activating stimuli | Guma et al.
to the p65 subunit of NF-kappa B abrogates established experimental 
colitis in mice. Nat. Med. 2:998–1004. doi:10.1038/nm0996-998
Pasparakis, M. 2009. Regulation of tissue homeostasis by NF-kappaB signal-
ling: implications for inflammatory diseases. Nat. Rev. Immunol. 9:778–
788. doi:10.1038/nri2655
Rius, J., M. Guma, C. Schachtrup, K. Akassoglou, A.S. Zinkernagel, V. Nizet, 
R.S. Johnson, G.G. Haddad, and M. Karin. 2008. NF-kappaB links innate 
immunity to the hypoxic response through transcriptional regulation of 
HIF-1alpha. Nature. 453:807–811. doi:10.1038/nature06905
Rothwarf, D.M., and M. Karin. 1999. The NF-kappa B activation pathway: a 
paradigm in information transfer from membrane to nucleus. Sci. STKE. 
1999:re1. doi:10.1126/stke.1999.5.re1
Rousseau, S., M. Papoutsopoulou, A. Symons, D. Cook, J.M. Lucocq, A.R. 
Prescott, A. O’Garra, S.C. Ley, and P. Cohen. 2008. TPL2-mediated acti-
vation of ERK1 and ERK2 regulates the processing of pre-TNF alpha 
in LPS-stimulated macrophages. J. Cell Sci. 121:149–154. doi:10.1242/ 
jcs.018671
Sfikakis, P.P. 2010. The first decade of biologic TNF antagonists in clinical 
practice: lessons learned, unresolved issues and future directions. Curr. 
Dir. Autoimmun. 11:180–210. doi:10.1159/000289205
Spehlmann, M.E., and L. Eckmann. 2009. Nuclear factor-kappa B in in-
testinal protection and destruction. Curr. Opin. Gastroenterol. 25:92–99. 
doi:10.1097/MOG.0b013e328324f857
Spehlmann, M.E., S.M. Dann, P. Hruz, E. Hanson, D.F. McCole, and 
L. Eckmann. 2009. CXCR2-dependent mucosal neutrophil influx 
protects against colitis-associated diarrhea caused by an attaching/ 
effacing lesion-forming bacterial pathogen. J. Immunol. 183:3332–3343. 
doi:10.4049/jimmunol.0900600
Stockmann, M., H. Schmitz, M. Fromm, W. Schmidt, G. Pauli, P. Scholz, 
E.O. Riecken, and J.D. Schulzke. 2000. Mechanisms of epithelial bar-
rier impairment in HIV infection. Ann. N. Y. Acad. Sci. 915:293–303. 
doi:10.1111/j.1749-6632.2000.tb05257.x
Tak, P.P., and G.S. Firestein. 2001. NF-kappaB: a key role in inflammatory 
diseases. J. Clin. Invest. 107:7–11. doi:10.1172/JCI11830
Tak, P.P., D.M. Gerlag, K.R. Aupperle, D.A. van de Geest, M. Overbeek, B.L. 
Bennett, D.L. Boyle, A.M. Manning, and G.S. Firestein. 2001. Inhibitor 
of nuclear factor kappaB kinase beta is a key regulator of synovial 
inflammation. Arthritis Rheum. 44:1897–1907. doi:10.1002/1529-
0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4
Vereecke, L., R. Beyaert, and G. van Loo. 2009. The ubiquitin-editing 
enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends 
Immunol. 30:383–391. doi:10.1016/j.it.2009.05.007
Wadsworth, S.A., D.E. Cavender, S.A. Beers, P. Lalan, P.H. Schafer, E.A. 
Malloy, W. Wu, B. Fahmy, G.C. Olini, J.E. Davis, et al. 1999. RWJ 67657, 
a potent, orally active inhibitor of p38 mitogen-activated protein kinase. 
J. Pharmacol. Exp. Ther. 291:680–687.
Xu, P., and R. Derynck. 2010. Direct activation of TACE-mediated 
ectodomain shedding by p38 MAP kinase regulates EGF receptor-
dependent cell proliferation. Mol. Cell. 37:551–566. doi:10.1016/ 
j.molcel.2010.01.034
Zhang, G.L., Y.F. Zou, X.L. Feng, H.J. Shi, X.F. Du, M.H. Shao, Y. Gu, and 
Q. Zhou. 2011. Association of the NFKBIA gene polymorphisms with 
susceptibility to autoimmune and inflammatory diseases: a meta-analysis. 
Inflamm. Res. 60:11–18. doi:10.1007/s00011-010-0216-2
Hsu, L.C., T. Enzler, J. Seita, A.M. Timmer, C.Y. Lee, T.Y. Lai, G.Y. Yu, L.C. 
Lai, V. Temkin, U. Sinzig, et al. 2011. IL-1-driven neutrophilia preserves 
antibacterial defense in the absence of the kinase IKK. Nat. Immunol. 
12:144–150. doi:10.1038/ni.1976
Izcue, A., J.L. Coombes, and F. Powrie. 2006. Regulatory T cells suppress sys-
temic and mucosal immune activation to control intestinal inflammation. 
Immunol. Rev. 212:256–271. doi:10.1111/j.0105-2896.2006.00423.x
Karin, M., and A. Lin. 2002. NF-kappaB at the crossroads of life and death. 
Nat. Immunol. 3:221–227. doi:10.1038/ni0302-221
Kaser, A., S. Zeissig, and R.S. Blumberg. 2010. Inflammatory bowel disease. Annu. 
Rev. Immunol. 28:573–621. doi:10.1146/annurev-immunol-030409-101225
Klement, J.F., N.R. Rice, B.D. Car, S.J. Abbondanzo, G.D. Powers, P.H. Bhatt, 
C.H. Chen, C.A. Rosen, and C.L. Stewart. 1996. IkappaBalpha defi-
ciency results in a sustained NF-kappaB response and severe widespread 
dermatitis in mice. Mol. Cell. Biol. 16:2341–2349.
Kotlyarov, A., A. Neininger, C. Schubert, R. Eckert, C. Birchmeier, H.D. Volk, 
and M. Gaestel. 1999. MAPKAP kinase 2 is essential for LPS-induced 
TNF-alpha biosynthesis. Nat. Cell Biol. 1:94–97. doi:10.1038/10061
Lawrence, T. 2009. The nuclear factor NF-kappaB pathway in inflammation. 
Cold Spring Harb. Perspect. Biol. 1:a001651. doi:10.1101/cshperspect 
.a001651
Lee, T.I., S.E. Johnstone, and R.A. Young. 2006. Chromatin immuno-
precipitation and microarray-based analysis of protein location. 
Nat. Protoc. 1:729–748. doi:10.1038/nprot.2006.98
Li, Q., and I.M. Verma. 2002. NF-kappaB regulation in the immune system. 
Nat. Rev. Immunol. 2:725–734. doi:10.1038/nri910
Liu, S.F., and A.B. Malik. 2006. NF-kappa B activation as a pathological 
mechanism of septic shock and inflammation. Am. J. Physiol. Lung Cell. 
Mol. Physiol. 290:L622–L645. doi:10.1152/ajplung.00477.2005
Lizzul, P.F., A. Aphale, R. Malaviya, Y. Sun, S. Masud, V. Dombrovskiy, and 
A.B. Gottlieb. 2005. Differential expression of phosphorylated NF- 
kappaB/RelA in normal and psoriatic epidermis and downregulation of 
NF-kappaB in response to treatment with etanercept. J. Invest. Dermatol. 
124:1275–1283. doi:10.1111/j.0022-202X.2005.23735.x
Madison, B.B., L. Dunbar, X.T. Qiao, K. Braunstein, E. Braunstein, and D.L. 
Gumucio. 2002. Cis elements of the villin gene control expression in 
restricted domains of the vertical (crypt) and horizontal (duodenum, 
cecum) axes of the intestine. J. Biol. Chem. 277:33275–33283. doi:10.1074/ 
jbc.M204935200
Miura, N., M. Yamamoto, M. Fukutake, N. Ohtake, S. Iizuka, A. Ishige, H. 
Sasaki, K. Fukuda, T. Yamamoto, and S. Hayakawa. 2005. Anti-CD3 
induces bi-phasic apoptosis in murine intestinal epithelial cells: possible 
involvement of the Fas/Fas ligand system in different T cell compart-
ments. Int. Immunol. 17:513–522. doi:10.1093/intimm/dxh231
Mucida, D., Y. Park, G. Kim, O. Turovskaya, I. Scott, M. Kronenberg, and 
H. Cheroutre. 2007. Reciprocal TH17 and regulatory T cell differen-
tiation mediated by retinoic acid. Science. 317:256–260. doi:10.1126/ 
science.1145697
Nenci, A., C. Becker, A. Wullaert, R. Gareus, G. van Loo, S. Danese, M. Huth, 
A. Nikolaev, C. Neufert, B. Madison, et al. 2007. Epithelial NEMO links 
innate immunity to chronic intestinal inflammation. Nature. 446:557–
561. doi:10.1038/nature05698
Neurath, M.F., S. Pettersson, K.H. Meyer zum Büschenfelde, and W. Strober. 
1996. Local administration of antisense phosphorothioate oligonucleotides 
